I read a compllation of research reports published by Cold Spring Harbor labs.
The papers were all about recent research into the genetic and proteinaceous basis of cellular translational control. I had a very strong feeling that this body
of work was soon to have serious clinical relevence. I was delighted upon recently attending a seminar where I that the U way soon be doing clinical trials of a new therapy for solid tumor cancers and fibrotic diseases based on this knowledge.